Vitiligo develops when the immune system attacks and destroys melanocytes, the cells responsible for producing skin pigment. This process leaves behind smooth, white patches that can appear anywhere on the body. An estimated 0.36% of the global population has been diagnosed with vitiligo, roughly 28.5 million people worldwide. No single cause explains every case. Instead, a combination of genetic susceptibility, immune system malfunction, and environmental triggers determines who develops it and when.
The Immune System Turns on Pigment Cells
At its core, vitiligo is an autoimmune condition. The body’s own immune cells, specifically a type of white blood cell called CD8+ T cells, become activated against melanocytes and begin destroying them. Researchers have found these activated immune cells concentrated at the edges of depigmented patches, right where color loss is actively spreading. The body also produces antibodies that target proteins on melanocyte surfaces, adding a second layer of immune attack.
This isn’t a one-time event. In most people with vitiligo, the immune assault continues over years, with periods of active spreading and periods of stability. The melanocytes don’t simply stop working. They are killed off, which is why color loss in vitiligo tends to be permanent without treatment.
Genetics Set the Stage
You don’t inherit vitiligo directly, but you can inherit a predisposition to it. Variations in more than 30 genes have been linked to increased risk, many of them involved in immune regulation. Two of the most studied are NLRP1, which helps control inflammatory responses, and PTPN22, which plays a role in how immune cells distinguish the body’s own tissue from foreign invaders. When these genes carry certain variants, the immune system is more likely to misfire against melanocytes.
About one in five people with vitiligo has at least one close relative (parent, sibling, or child) who also has the condition. That said, most people with a family history never develop it themselves. Genetics loads the gun, but something else pulls the trigger.
Environmental Triggers That Start the Process
For people with genetic susceptibility, specific environmental exposures can set off the first patches of color loss. Chemical exposure is one of the most significant and most overlooked triggers. A study of vitiligo patients found that 94.6% reported exposure to household chemicals before their condition began. In nearly 65% of those cases, the first patch of vitiligo appeared at the same body site where the chemical contact occurred.
Phenolic compounds deserve special attention. These chemicals, found in certain rubber products, adhesives, cleaning agents, hair dyes, and industrial materials, are structurally similar to the building blocks of melanin. When they enter the skin, melanocytes can mistake them for normal pigment precursors and attempt to process them. This generates toxic byproducts inside the cell and can trigger the immune response that leads to widespread depigmentation. Outbreaks of occupational vitiligo have been traced to rubber products containing compounds like para-tert-butylphenol, a known depigmenting agent that sometimes appears as a manufacturing byproduct.
Emotional stress is another commonly reported trigger. While stress alone doesn’t cause vitiligo, it can dysregulate immune function in ways that tip a genetically susceptible person into active disease. Many people recall their first patches appearing during or shortly after a period of intense psychological stress.
Skin Injury Can Trigger New Patches
People who already have vitiligo are susceptible to something called the Koebner phenomenon: new patches of color loss appearing at sites of skin injury. Any damage that penetrates through the outer and middle layers of skin can trigger it. This includes cuts, burns, sunburns, surgical wounds, tattoos, insect bites, and even injections or piercings. New depigmented patches typically appear within 10 to 20 days of the injury and tend to follow a linear pattern along the wound site.
This is one reason dermatologists often advise people with active vitiligo to protect their skin from unnecessary trauma and to be cautious about elective procedures like tattooing, which can create new areas of color loss rather than camouflaging existing ones.
Two Types With Different Patterns
Not all vitiligo behaves the same way, and the type a person develops offers clues about what’s happening beneath the surface.
Non-segmental vitiligo is the more common form. Patches appear symmetrically on both sides of the body, such as both hands, both knees, or both sides of the face. It tends to spread slowly, with new patches developing on and off throughout a person’s lifetime. Color loss can occur anywhere, including the face, hands, arms, feet, and areas around body openings.
Segmental vitiligo behaves differently. It affects only one side or one segment of the body, such as one arm or one side of the face. It spreads rapidly for about 6 to 12 months, then stabilizes and rarely progresses further. Hair in the affected area may also turn white. Most people who develop segmental vitiligo do so before age 30. Because it stabilizes on its own, it’s thought to involve a more localized immune process rather than the body-wide autoimmune dysfunction seen in the non-segmental type.
The Link to Other Autoimmune Conditions
Because vitiligo stems from immune system dysfunction, it frequently occurs alongside other autoimmune diseases. In a review of nearly 1,100 patients with vitiligo, about 20% had at least one additional autoimmune condition.
Thyroid disease is the most common companion, affecting 12.3% of vitiligo patients overall. The connection is particularly strong in women: 18.5% of women with vitiligo had comorbid thyroid disease compared to 5.1% of men. Alopecia areata, an autoimmune condition causing patchy hair loss, was the second most common at 3.8%. Other conditions seen at higher-than-expected rates included lupus, pernicious anemia (a condition where the body can’t absorb vitamin B12 properly), inflammatory bowel disease, and Sjögren syndrome.
This clustering doesn’t mean vitiligo causes these other conditions or vice versa. Rather, they share overlapping genetic risk factors that make the immune system prone to attacking the body’s own tissues. If you have vitiligo, screening for thyroid function is a standard recommendation because thyroid problems are so common in this group and easy to manage once detected.
Who Develops It and When
Vitiligo affects all skin tones and ethnicities, though it’s more visually apparent on darker skin. It can begin at any age, but roughly half of all cases start before age 20. The condition affects men and women at similar rates, though women are more likely to seek treatment and more likely to develop associated thyroid problems.
There’s no way to predict with certainty who will develop vitiligo or when. A person might carry the genetic variants, encounter a chemical trigger, and experience significant stress all within the same period, and patches appear. Another person with identical genes might go their entire life without a single white spot. The interplay between genetic predisposition, immune regulation, and environmental exposure is what ultimately determines whether melanocytes come under attack.